Stockreport

Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF Under the terms of the offered transaction, Ono will make a cash purchase of all outstanding shares of Deciphera's common stock at $25.60 per share and subsequently mer [Read more]